Seller record · arsynl.com

ARSYNL Rx

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The product pages, terms and privacy policy stop at a licensed pharmacy partner and participating pharmacies. 1 more criterion also fails; see the table below.

At a glance

ARSYNL Rxarsynl.com

6/8criteria passed
Price
Semaglutide $219, tirzepatide $269 a month
Sells
compounded semaglutide, compounded tirzepatide, and 8 more
FDA letters
None on file
Visit ARSYNL RxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A veteran-founded telehealth service selling compounded semaglutide and tirzepatide, a tirzepatide transdermal spray, and sermorelin, NAD+ and glutathione, alongside testosterone and hair loss treatments. It prints a monthly price on every product page and names no filling pharmacy.

Operating entity ARSYNL LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSarsynl.com/products/compounded-semaglutide
S2Prescription gatingPASScarerx.arsynl.com
S3Pharmacy identificationFAILarsynl.com/terms-of-use, arsynl.com/products/advanced-tirzepatide
S4Compounding disclosurePASSarsynl.com/products/compounded-semaglutide, arsynl.com/products/sermorelin
S5Analytical documentationFAILarsynl.com/products/compounded-semaglutide
S6Business addressPASSarsynl.com/contact, arsynl.com/privacy-policy
S7Price disclosurePASSarsynl.com/products/compounded-semaglutide, arsynl.com/products/advanced-tirzepatide, arsynl.com/products/sermorelin
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSPrescription products require an online consultation with a licensed provider who decides whether a prescription is appropriate, and every intake is reviewed by a United States board-certified physician.Source: arsynl.com/products/compounded-semaglutide.
S2PASSThe qualify buttons open a health assessment that takes the buyer through health questions before checkout, and the plan section of each product page leads to that assessment rather than to a cart.Source: carerx.arsynl.com.
S3FAILThe site names no filling pharmacy. The product pages, terms and privacy policy stop at a licensed pharmacy partner and participating pharmacies.Source: arsynl.com/terms-of-use, arsynl.com/products/advanced-tirzepatide.
S4PASSCompounded medications are not FDA-approved, printed directly under the price on each product page, and the sermorelin and NAD+ pages answer the same question in their own sections.Source: arsynl.com/products/compounded-semaglutide, arsynl.com/products/sermorelin.
S5FAILNo certificate, lot report or test document appears on the product pages, the terms, the privacy policy or the about page.Source: arsynl.com/products/compounded-semaglutide.
S6PASSARSYNL LLC at 8 The Green Suite B, Dover, DE 19901, printed in the footer, on the contact page and in the privacy policy and privacy notice.Source: arsynl.com/contact, arsynl.com/privacy-policy.
S7PASSSemaglutide at $219 a month, tirzepatide at $269 a month, sermorelin at $169.99 a month or $480 for three months, NAD+ at $149 a month and glutathione at $139 a month.Source: arsynl.com/products/compounded-semaglutide, arsynl.com/products/advanced-tirzepatide, arsynl.com/products/sermorelin.
S8PASSNo FDA warning letter names ARSYNL Rx or the operating entity ARSYNL LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, tirzepatide transdermal spray, sermorelin, NAD+ injection and nasal spray, glutathione, MIC+B12, testosterone, low-dose naltrexone, metformin.

Unpaid link. ARSYNL Rx does not pay the site, and nothing is earned when it is used. Funding.

Visit ARSYNL Rx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.